| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Bienaime Jean Jacques is a Director at BIOMARIN PHARMACEUTICAL INC with holdings across 6 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $30.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 17, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $91.73 | $458,650.00 | -2.1% | |
| May 12, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $89.23 | $446,150.00 | -2.1% | |
| May 8, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $96.09 | $960,850.00 | -2.1% | |
| Apr 27, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $95.72 | $478,600.00 | -2.1% | |
| Apr 25, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $94.00 | $470,000.00 | -2.1% | |
| Mar 16, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $91.69 | $916,900.00 | -2.5% | |
| Mar 13, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $92.68 | $463,400.00 | -2.4% | |
| Mar 10, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 11,000 | $90.59 | $996,530.00 | -2.6% | |
| Jan 26, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $84.22 | $842,200.00 | -2.8% | |
| Jan 11, 2017 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $90.58 | $724,600.00 | -2.3% |